Authors: HOKI Y FUJIMORI A POMMIER Y

Citation: Y. Hoki et al., DIFFERENTIAL CYTOTOXICITY OF CLINICALLY IMPORTANT CAMPTOTHECIN DERIVATIVES IN P-GLYCOPROTEIN OVEREXPRESSING CELL-LINES, Cancer chemotherapy and pharmacology, 40(5), 1997, pp. 433-438

Authors: FUJIMORI A HOKI Y POPESCU NC POMMIER Y

Citation: A. Fujimori et al., SILENCING AND SELECTIVE METHYLATION OF THE NORMAL TOPOISOMERASE-I GENE IN CAMPTOTHECIN-RESISTANT CEM C2 HUMAN LEUKEMIA-CELLS/, Oncology research, 8(7-8), 1996, pp. 295-301

Authors: FUJIMORI A GUPTA M HOKI Y POMMIER Y

Citation: A. Fujimori et al., ACQUIRED CAMPTOTHECIN RESISTANCE OF HUMAN BREAST-CANCER MCF-7 C4 CELLS WITH NORMAL TOPOISOMERASE-I AND ELEVATED DNA-REPAIR/, Molecular pharmacology, 50(6), 1996, pp. 1472-1478

Authors: GOLDWASSER F SHIMIZU T JACKMAN J HOKI Y OCONNOR PM KOHN KW POMMIER Y

Citation: F. Goldwasser et al., CORRELATIONS BETWEEN S AND G(2) ARREST AND THE CYTOTOXICITY OF CAMPTOTHECIN IN HUMAN COLON-CARCINOMA CELLS, Cancer research, 56(19), 1996, pp. 4430-4437

Authors: GUPTA M ABDELMEGEED M HOKI Y KOHLHAGEN G PAULL K POMMIER Y

Citation: M. Gupta et al., EUKARYOTIC DNA TOPOISOMERASES MEDIATED DNA CLEAVAGE INDUCED BY A NEW INHIBITOR - NSC-665517, Molecular pharmacology, 48(4), 1995, pp. 658-665

Authors: FUJIMORI A HARKER WG KOHLHAGEN G HOKI Y POMMIER Y

Citation: A. Fujimori et al., MUTATION AT THE CATALYTIC SITE OF TOPOISOMERASE-I IN CEM C2, A HUMAN LEUKEMIA-CELL LINE RESISTANT TO CAMPTOTHECIN/, Cancer research, 55(6), 1995, pp. 1339-1346